Options Strategist Prepared for Deal or No Deal at Genzyme (GENZ)
July 27, 2010 at 12:53 PM EDT
GENZ – Genzyme Corp. – Shares of the world’s largest maker of drugs for rare genetic diseases are down slightly by 0.35% to arrive at $67.16 as of 11:55 am (ET) after earlier rallying 1.25% to briefly touch a new 52-week high of $68.23. This marks a 27.7% increase in its [...]
